Skip to main content

What Our Partners Say

We share a common vision with our partners in wanting to make a difference and develop new and advanced medicines that make a real impact on patients’ lives. Hear what they have to say about their partnering journey with us.

Latest Articles on What Our Partners Say

Public-Private Partnerships

Our Partners: Bioharmony Therapeutics

Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.

Read more
Our Partners: ViraTherapeutics
What Our Partners Say Viratherapeutics
What Our Partners Say

Our Partners: ViraTherapeutics

Lisa Egerer, COO and Patrik Erlmann, Head of Research at ViraTherapeutics talk about their partnering journey with Boehringer Ingelheim.
Read more
Our Partners: Harvard Fibrosis Network
Our Partners: Harvard Fibrosis Network
What Our Partners Say

Our Partners: Harvard Fibrosis Network

Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.
Read more

Links

See more

Boehringer Ingelheim Venture Fund

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
See more